Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 155.00 | |
50 mg | In stock | $ 239.00 | |
100 mg | In stock | $ 372.00 | |
200 mg | In stock | $ 549.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | 2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer |
In vitro | The pharmacologically active metabolite 2-hydroxy-flutamide, this principle metabolite increased CYP3A metabolism of midazolam in human microsomes (30%) and hepatocytes (110%)[1]. |
Molecular Weight | 292.21 |
Formula | C11H11F3N2O4 |
CAS No. | 52806-53-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25mg/ml(85.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2-hydroxy Flutamide 52806-53-8 Endocrinology/Hormones Androgen Receptor Inhibitor inhibit prostate cancer HFT Flutamide 2 hydroxy Flutamide 2hydroxy Flutamide Hydroxyflutamide inhibitor